Back to top
more

CVS Health (CVS)

(Real Time Quote from BATS)

$55.28 USD

55.28
1,438,095

-1.66 (-2.92%)

Updated Sep 11, 2024 10:14 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 6% (234 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Sheraz Mian headshot

Previewing Retail Sector Earnings as Inflation Climbs

With respect to the Retail sector's 2022 Q1 earnings season scorecard, we now have results from 21 of the 34 retailers in the S&P 500 index. Here's how the companies are performing so far and what to expect...

Here's Why You Should Hold on to CVS Health (CVS) For Now

Investors are optimistic about CVS Health's (CVS) better-than-expected results and strong retail sales.

The Zacks Analyst Blog Highlights AbbVie, Qualcomm, Linde, CVS Health Corp, and Booking Holdings

AbbVie, Qualcomm, Linde, CVS Health Corp, and Booking Holdings are part of Zacks top Analyst Blog.

Sheraz Mian headshot

Q1 Earnings Scorecard and Analyst Reports for AbbVie, QUALCOMM & Linde

Today's Research Daily features a real-time update on the Q1 earnings season and new research reports on AbbVie (ABBV), QUALCOMM (QCOM), and Linde(LIN).

CVS Health (CVS) Q1 Earnings Top Estimates, '22 EPS View Up

CVS Health (CVS) reports better-than-expected results for Q1, with robust segmental performance driving the top line.

CVS Health (CVS) Surpasses Q1 Earnings and Revenue Estimates

CVS Health (CVS) delivered earnings and revenue surprises of 3.74% and 1.71%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Herbalife LTD. (HLF) Q1 Earnings Beat Estimates

Herbalife LTD. (HLF) delivered earnings and revenue surprises of 13.79% and 2.95%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Can CVS Health (CVS) Keep the Earnings Surprise Streak Alive?

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

TravelCenters of America (TA) Q1 Earnings and Revenues Top Estimates

TravelCenters (TA) delivered earnings and revenue surprises of 2,160% and 4.40%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

CVS Health (CVS) closed at $100.85 in the latest trading session, marking a -0.57% move from the prior day.

CVS Health (CVS) Earnings Expected to Grow: Should You Buy?

CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CVS Health (CVS) to Report Q1 Earnings: What's in the Cards?

Increased digital health adoption and growing pharmacy sales are likely to have contributed to CVS Health's (CVS) Q1 performance.

Is Legg Mason Low Volatility High Dividend ETF (LVHD) a Strong ETF Right Now?

Smart Beta ETF report for LVHD

CVS Health (CVS) Stock Moves -1.37%: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $105.18, marking a -1.37% move from the previous day.

Sheraz Mian headshot

Top Research Reports for Johnson & Johnson, Roche & Raytheon

Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Roche Holding AG (RHHBY), and Raytheon Technologies Corporation (RTX).

CVS Health (CVS) Gains But Lags Market: What You Should Know

CVS Health (CVS) closed the most recent trading day at $103.86, moving +0.43% from the previous trading session.

Rite Aid (RAD) Reports Q4 Loss, Tops Revenue Estimates

Rite Aid (RAD) delivered earnings and revenue surprises of -185.96% and 2.02%, respectively, for the quarter ended February 2022. Do the numbers hold clues to what lies ahead for the stock?

CVS Health (CVS) Gains But Lags Market: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $104.98, marking a +0.32% move from the previous day.

CVS Health (CVS) Gains As Market Dips: What You Should Know

CVS Health (CVS) closed the most recent trading day at $104.64, moving +0.18% from the previous trading session.

The Zacks Analyst Blog Highlights Merck, CVS Health, American Tower, QUALCOMM and Analog Devices

Merck, CVS Health, American Tower, QUALCOMM and Analog Devices are part of top Analyst article.

Sheraz Mian headshot

Top Analyst Reports for Merck, CVS Health & American Tower

Today's Research Daily features new research reports on 16 major stocks, including Merck & Co. Inc. (MRK), CVS Health Corporation (CVS), and American Tower Corporation (AMT).

CVS Health (CVS) Stock Moves -0.54%: What You Should Know

CVS Health (CVS) closed the most recent trading day at $99.46, moving -0.54% from the previous trading session.

Here's Why You Should Retain CVS Health (CVS) Stock For Now

Investors are optimistic about CVS Health (CVS) owing to continued progress in its consumer-centric digital solutions.

CVS Health (CVS) Dips More Than Broader Markets: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $103.55, marking a -1.08% move from the previous day.